Allogene Therapeutics ALLO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's common stock?
- Allogene Therapeutics (ALLO) reported common stock of 400M in Q1 2026.
- How has Allogene Therapeutics's common stock changed year-over-year?
- Allogene Therapeutics's common stock decreased by 0.0% year-over-year, from 400M to 400M.
- What is the long-term trend for Allogene Therapeutics's common stock?
- Over 5 years (2020 to 2025), Allogene Therapeutics's common stock has grown at a 391.1% compound annual growth rate (CAGR), from 140K to 400M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).